MSB
Click for more information
1.03% 98.0¢ mesoblast limited

https://www.newsmax.com/health/dr-crandall/stem-cells-heart-failu...

  1. tyewc
    37 Posts.
    lightbulb Created with Sketch. 28
    clock Created with Sketch.
    13/03/24
    11:48
    Post #: 72862750
    https://www.newsmax.com/health/dr-crandall/stem-cells-heart-failure-stroke/2024/03/06/id/1156243/

    Wednesday, March 6, 2024 04:22 PM

    By: Chauncey Crandall, M.D.


    Patients with mild or moderate heart failure who have high levels of inflammation responded well to stem cell injections, and experienced a decline in their risk of heart attacks, strokes, and heart-related death, according to clinical trial results.

    Stem cells injected into targeted areas of a failing heart become activated by inflammation and start pumping out beneficial biochemicals, explained lead researcher Dr. Emerson Perin, medical director of the Texas Heart Institute in Houston.

    “These cells are little factories of different proteins, cytokines and other products that then have an effect locally on the heart muscle cells,” Perin said, adding that the cells also help improve the health of blood vessels both large and small.

    Researchers recruited 537 people suffering from advanced heart failure with reduced ejection fraction, which is when the main pumping chamber in the left side of the heart is significantly weakened. Half of the patients chosen at random received 150 million stem cells into targeted areas of still-working heart muscle, delivered through 15 to 20 injections in a single procedure.

    All the patients who got stem cells experienced a 65 percent reduction in nonfatal heart attacks and strokes. Participants with high levels of inflammation were 79 percent less likely to have nonfatal heart attacks or strokes after stem cell therapy.


    MSB Price at posting: 38.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 12  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
98.0¢ 		Change
0.010(1.03%) 		Mkt cap ! $1.118B
Open High Low Value Volume
96.0¢ 99.0¢ 95.5¢ $5.286M 5.409M

Buyers (Bids)

No. Vol. Price($)
3 91218 98.0¢
 

Sellers (Offers)

Price($) Vol. No.
99.0¢ 63577 4
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.